Han Koo
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Melanoma and MAPK Pathways
- Bacillus and Francisella bacterial research
- PI3K/AKT/mTOR signaling in cancer
- Cell death mechanisms and regulation
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 3
- Metabolism, Diabetes, and Cancer 2
- Cancer therapeutics and mechanisms 2
- Mechanisms of cancer metastasis 2
- Chemical Synthesis and Analysis 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Cancer, Hypoxia, and Metabolism 4
- MicroRNA in disease regulation 1
- Co-authors
- Nancy A. Staffend (1 shared paper)Kathryn M. Eisenmann (1 shared paper)Matthew W. VanBrocklin (1 shared paper)George F. Vande Woude (3 shared papers)Young Il Yeom (9 shared papers)Nicholas S. Duesbery (1 shared paper)Stephen H. Leppla (1 shared paper)Craig P. Webb (1 shared paper)
- Journals
- Cancers (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Cells (1 paper)Molecules and Cells (1 paper)Nature Communications (1 paper)
- Partner nations
- South KoreaUnited States
In The Last Decade
Han Koo
16 papers receiving 445 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 144
- Molecular Biology 371
- Biotechnology 42
- Oncology 122
- Toxicology 8
Countries citing papers authored by Han Koo
This map shows the geographic impact of Han Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Koo more than expected).
Fields of papers citing papers by Han Koo
This network shows the impact of papers produced by Han Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Koo. The network helps show where Han Koo may publish in the future.
Co-authors
The 25 scholars most cited alongside Han Koo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad. | 2003 | 120 |
| 2 | 2001 | 80 | |
| 3 | Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. | 1996 | 72 |
| 4 | 2015 | 48 | |
| 5 | 2016 | 43 | |
| 6 | 1999 | 28 | |
| 7 | 2015 | 26 | |
| 8 | 2023 | 10 | |
| 9 | 2019 | 10 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 5 | |
| 12 | 2022 | 1 | |
| 13 | Chromosomal Translocation Occuring Congenital Coloboma in Both Eyes. | 1992 | 1 |
| 14 | 2022 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2024 | 1 |
About Han Koo
Han Koo is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Genetics and Biochemistry, having authored 16 papers that have together received 454 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer therapeutics and mechanisms (2 papers), Mechanisms of cancer metastasis (2 papers), Chemical Synthesis and Analysis (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (144 citations), Molecular Biology (371 citations), Biotechnology (42 citations), Oncology (122 citations) and Toxicology (8 citations). Han Koo has collaborated with scholars based in South Korea and United States. Frequent co-authors include Nancy A. Staffend, Kathryn M. Eisenmann, Matthew W. VanBrocklin, George F. Vande Woude, Young Il Yeom, Nicholas S. Duesbery, Stephen H. Leppla, Craig P. Webb, James H. Resau and Shahriar Koochekpour. Their work appears in journals such as Cancers, JNCI Journal of the National Cancer Institute, Cells, Molecules and Cells and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.